MedPath

Effect of Intravenous Lignocaine, Dexmedetomidine and their combination on pulse,blood pressure and oxygen saturation during operation, pain after operation and quality of recovery in patients undergoing uterus removal operation by robot

Not Applicable
Completed
Conditions
Health Condition 1: N958- Other specified menopausal and perimenopausal disorders
Registration Number
CTRI/2019/09/021323
Lead Sponsor
AIIMS RISHIKESH
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
96
Inclusion Criteria

1.Female patients aged 30-65 years,

2.ASA grade I & II

3.Patients undergoing elective Robotic Abdominal

Hysterectomy under general anaesthesia will be selected

Exclusion Criteria

1.ASA grade III & IV patients

2.Age >65 years

3.BMI >35kg/m2

4.Allergy to local anaesthetic agents

5.History of use of opioid, analgesics and psychotropic drugs and beta blockers, substance abuse preoperatively

6.Uncontrolled hypertension, A-V conduction block, history of sleep apnoea

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess post operative pain as measured by VASTimepoint: 4 hours after surgery
Secondary Outcome Measures
NameTimeMethod
1.Time to first bowel sounds and flatus <br/ ><br>2.Intraoperative consumption of propofol, fentanyl and vecuronium <br/ ><br>3.Postoperative fentanyl requirement <br/ ><br>4.QoR15 score on day 1,2 and on day of dischargeTimepoint: DAY 0,1,2 AND ON THE DAY OF DISCHARGE
© Copyright 2025. All Rights Reserved by MedPath